Curis
CRIS
#10272
Rank
NZ$23.3 M
Marketcap
NZ$1.80
Share price
1.94%
Change (1 day)
-68.65%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -NZ$56.22 Million

According to Curis's latest financial reports the company's current earnings are NZ$11.65 Million. In 2024 the company made an earning of -NZ$73.44 Million, an increase over its 2023 earnings that were of -NZ$77.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$56.22 Million-23.45%
2024 -NZ$73.44 Million-5.77%
2023 -NZ$77.94 Million-13.1%
2022 -NZ$89.68 Million27.52%
2021 -NZ$70.33 Million65.09%
2020 -NZ$42.6 Million-9.1%
2019 -NZ$46.87 Million-4.73%
2018 -NZ$49.19 Million-41.95%
2017 -NZ$84.73 Million-14.37%
2016 -NZ$98.95 Million3.55%
2015 -NZ$95.55 Million271.52%
2014 -NZ$25.72 Million76.64%
2013 -NZ$14.56 Million
2011 -NZ$12.37 Million27.76%
2010 -NZ$9.68 Million-43.87%
2009 -NZ$17.25 Million-23.44%
2008 -NZ$22.53 Million56.66%
2007 -NZ$14.38 Million-16.71%
2006 -NZ$17.27 Million-36.92%
2005 -NZ$27.37 Million156.25%
2004 -NZ$10.68 Million-37.24%
2003 -NZ$17.02 Million-93.34%
2002 -NZ$0.26 Billion86.79%
2001 -NZ$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Exelixis
EXEL
NZ$1.49 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.44 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.34 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.79 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$42.45 Million-24.06%๐Ÿ‡บ๐Ÿ‡ธ USA